Coherus Bio (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 257,244 | 211,042 | 326,551 | 475,824 | 356,071 |
| Cost of Goods | 158,992 | 70,083 | 57,591 | 37,667 | 17,078 |
| Gross Profit | 98,252 | 140,959 | 268,960 | 438,157 | 338,993 |
| Operating Expenses | 302,443 | 397,922 | 533,409 | 282,505 | 231,303 |
| Operating Income | -203,199 | -256,880 | -263,858 | 156,319 | 107,768 |
| Interest Expense | 40,542 | 32,474 | 22,959 | 21,166 | 17,601 |
| Other Income | 5,469 | -2,400 | -283 | 554 | 2,608 |
| Pre-tax Income | -238,272 | -291,754 | -287,100 | 135,707 | 92,775 |
| Income Tax | -380 | N/A | N/A | 3,463 | 2,942 |
| Net Income Continuous | -237,892 | -291,754 | -287,100 | 132,244 | 89,833 |
| Net Income | $-237,892 | $-291,754 | $-287,100 | $132,244 | $89,833 |
| EPS Basic Total Ops | -2.53 | -3.76 | -3.81 | 1.85 | 1.29 |
| EPS Basic Continuous Ops | -2.53 | -3.76 | -3.81 | 1.85 | 1.29 |
| EPS Diluted Total Ops | -2.53 | -3.76 | -3.81 | 1.62 | 1.23 |
| EPS Diluted Continuous Ops | -2.53 | -3.76 | -3.81 | 1.58 | 1.23 |
| EPS Diluted Before Non-Recurring Items | -2.43 | -3.68 | -3.81 | 1.62 | 1.23 |
| EBITDA(a) | $-199,408 | $-253,181 | $-260,404 | $159,207 | $111,027 |